JP2011523636A5 - - Google Patents

Download PDF

Info

Publication number
JP2011523636A5
JP2011523636A5 JP2011508937A JP2011508937A JP2011523636A5 JP 2011523636 A5 JP2011523636 A5 JP 2011523636A5 JP 2011508937 A JP2011508937 A JP 2011508937A JP 2011508937 A JP2011508937 A JP 2011508937A JP 2011523636 A5 JP2011523636 A5 JP 2011523636A5
Authority
JP
Japan
Prior art keywords
vivo imaging
subject
polynucleotide
vivo
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011508937A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011523636A (ja
Filing date
Publication date
Priority claimed from GBGB0808834.6A external-priority patent/GB0808834D0/en
Application filed filed Critical
Publication of JP2011523636A publication Critical patent/JP2011523636A/ja
Publication of JP2011523636A5 publication Critical patent/JP2011523636A5/ja
Pending legal-status Critical Current

Links

JP2011508937A 2008-05-15 2009-05-15 うつ病に関するバイオマーカー Pending JP2011523636A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0808834.6A GB0808834D0 (en) 2008-05-15 2008-05-15 Biomarkers for depression
GB0808834.6 2008-05-15
PCT/EP2009/055943 WO2009138499A2 (en) 2008-05-15 2009-05-15 Biomarkers for depression

Publications (2)

Publication Number Publication Date
JP2011523636A JP2011523636A (ja) 2011-08-18
JP2011523636A5 true JP2011523636A5 (https=) 2012-06-28

Family

ID=39571408

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011508937A Pending JP2011523636A (ja) 2008-05-15 2009-05-15 うつ病に関するバイオマーカー

Country Status (6)

Country Link
US (1) US20110064655A1 (https=)
EP (1) EP2281066A2 (https=)
JP (1) JP2011523636A (https=)
CN (1) CN102099492A (https=)
GB (1) GB0808834D0 (https=)
WO (1) WO2009138499A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808833D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression
GB0808832D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression
US9920371B2 (en) 2011-09-22 2018-03-20 Medvet Sciences Pty. Ltd. Screening method
CN103571849B (zh) * 2012-08-06 2015-05-13 北京市理化分析测试中心 用于检测抑郁症的基因及其检测方法和试剂盒
CN105177117A (zh) * 2015-07-03 2015-12-23 张理义 重症抑郁障碍生物标记物、筛选方法及试剂盒
KR102047479B1 (ko) * 2018-01-24 2019-11-21 전남대학교산학협력단 노년기우울증 검출방법 및 진단키트
CN113444802B (zh) * 2021-07-01 2024-02-06 复旦大学附属肿瘤医院 Htr1a在乳腺癌诊断、治疗和预后中的应用
WO2024215722A1 (en) * 2023-04-10 2024-10-17 Board Of Regents, The University Of Texas System Methods and compositions for diagnosing and treating depression and suicide risk

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7247442B1 (en) * 1998-05-12 2007-07-24 Human Genome Sciences, Inc. Antibodies to HHPEN62 polypeptide
WO2004047727A2 (en) * 2002-11-01 2004-06-10 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for diagnosing and treating mood disorders
US20050209181A1 (en) * 2003-11-05 2005-09-22 Huda Akil Compositions and methods for diagnosing and treating mental disorders
DK1766077T3 (da) * 2004-06-21 2012-07-16 Univ Leland Stanford Junior Differentielt udtrykte gener og veje i bipolar forstyrrelse og/eller alvorlig depressiv forstyrrelse
WO2008020435A2 (en) * 2006-08-15 2008-02-21 Quark Pharmaceuticals, Inc Compositions and methods for treatment of mood disorders
GB0808833D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression
GB0808832D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression

Similar Documents

Publication Publication Date Title
JP2011523636A5 (https=)
Burns et al. Proteomic research in sarcomas–current status and future opportunities
JP2011523637A5 (https=)
DE502005005337D1 (de) Mehrschichtfolie
IN2014DN04226A (https=)
Wolfort et al. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade
JP2007505908A5 (https=)
EA201100301A1 (ru) Daa-пиридин в качестве лиганда периферического бензодиазепинового рецептора для диагностической визуализации и фармацевтического лечения
JP2009542332A5 (https=)
JP2012509525A5 (ja) データ処理システム
JP2008527423A5 (https=)
WO2009047328A3 (en) Combination of single photon emission computed tomography and optical imaging detector
Balta et al. Neutrophil-to-lymphocyte ratio in prognosis of gastric cancer
JP2009065635A5 (https=)
WO2006093966A3 (en) Sem cathodoluminescent imaging using up-converting nanophosphors
AU2003242666A8 (en) Imaging method and device for carrying out said method
JP2011523638A5 (https=)
EA201100253A1 (ru) Глутаминилциклаза в качестве диагностического/прогностического индикатора нейродегенеративных заболеваний
Qiu et al. Hepatitis B core-related antigen as a promising serological marker for monitoring hepatitis B virus cure
JP2008539782A5 (https=)
JP2011102372A5 (https=)
Kumagai et al. Atrial giant cell myocarditis after atrial fibrillation ablation
JP2005253755A5 (https=)
WO2005090267A3 (en) Methods to prepare carbon-isotope organohalides with high specific radioactivity from carbon-isotope monoxide
Aigner et al. SUVmax—Δ makes the difference